Martin Shkreli Takes Aim At Capricor — Stock Sinks

Shares of Capricor Therapeutics, Inc. (NASDAQ:CAPR) plummeted Monday due to a short call from controversial former pharmaceutical executive Martin Shkreli.CAPR stock is plunging. See the real-time price action here. "HOPE-3, aka COPE-3"Shkreli publicly identified Capricor as a short target in a social media post. He expressed skepticism about the company’s cell therapy approach and its clinical trial data for its lead candidate, deramiocel. Read Next: Michael Burry Unchained: ‘Big Short’ Attacks Nvidia On S ...